Hartford Financial Management’s Fennec Pharmaceuticals FENC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$420K Buy
50,646
+798
+2% +$6.62K 0.11% 112
2025
Q1
$304K Hold
49,848
0.06% 146
2024
Q4
$315K Buy
49,848
+1,000
+2% +$6.32K 0.06% 145
2024
Q3
$244K Hold
48,848
0.05% 151
2024
Q2
$298K Buy
48,848
+1,050
+2% +$6.42K 0.06% 144
2024
Q1
$532K Buy
47,798
+450
+1% +$5K 0.11% 130
2023
Q4
$531K Buy
47,348
+2,000
+4% +$22.4K 0.12% 130
2023
Q3
$341K Hold
45,348
0.09% 142
2023
Q2
$400K Buy
45,348
+4,000
+10% +$35.3K 0.1% 139
2023
Q1
$344K Buy
41,348
+1,500
+4% +$12.5K 0.09% 140
2022
Q4
$383K Hold
39,848
0.1% 136
2022
Q3
$323K Buy
39,848
+5,000
+14% +$40.5K 0.09% 139
2022
Q2
$197K Hold
34,848
0.05% 151
2022
Q1
$195K Hold
34,848
0.05% 150
2021
Q4
$153K Buy
34,848
+6,000
+21% +$26.3K 0.04% 159
2021
Q3
$272K Hold
28,848
0.07% 141
2021
Q2
$210K Sell
28,848
-5,000
-15% -$36.4K 0.05% 148
2021
Q1
$210K Sell
33,848
-5,000
-13% -$31K 0.05% 146
2020
Q4
$289K Hold
38,848
0.08% 137
2020
Q3
$235K Sell
38,848
-10,700
-22% -$64.7K 0.07% 137
2020
Q2
$414K Buy
49,548
+7,400
+18% +$61.8K 0.13% 120
2020
Q1
$250K Buy
42,148
+7,148
+20% +$42.4K 0.1% 126
2019
Q4
$227K Buy
35,000
+5,000
+17% +$32.4K 0.07% 145
2019
Q3
$144K Buy
30,000
+9,700
+48% +$46.6K 0.05% 169
2019
Q2
$81K Buy
20,300
+8,000
+65% +$31.9K 0.03% 188
2019
Q1
$60K Buy
12,300
+2,300
+23% +$11.2K 0.02% 203
2018
Q4
$64K Hold
10,000
0.02% 200
2018
Q3
$82K Sell
10,000
-1,000
-9% -$8.2K 0.03% 200
2018
Q2
$115K Buy
11,000
+2,000
+22% +$20.9K 0.04% 183
2018
Q1
$108K Buy
9,000
+6,850
+319% +$82.2K 0.05% 153
2017
Q4
$21K Buy
2,150
+1,000
+87% +$9.77K 0.01% 218
2017
Q3
$12K Buy
+1,150
New +$12K 0.01% 282